Bioextrax AB (publ)

Bioextrax AB (publ)

BIOEX.ST
Bioextrax AB (publ)SE flagStockholm Stock Exchange
2.81
SEK
-0.14
- -
112.72MMarket Cap
Bioextrax AB (publ)
BIOEX.ST
(Stockholm Stock Exchange)

Recent

price

2.81

P/E

ratio

- -

div

yld

- -

ROIC.AI

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
- -
- -
0.02
0.02
0.08
0.02
0.02
0.02
Revenue per Share
-0.01
- -
-0.06
-0.19
-0.42
-0.78
-1.09
-0.81
-0.52
-0.45
-0.44
Basic EPS, GAAP
-0.01
- -
0.03
-0.36
-0.33
-0.7
-1.03
-0.87
-0.57
-0.66
-0.32
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.01
0.01
-0.05
-0.26
-0.31
-0.62
-0.58
0.4
0.11
0.23
0.41
Book Value per Share
- -
0.01
0.02
0.12
0.12
0.55
1.85
0.77
0.79
0.54
0.41
Tangible Book Value per Share
15
15
15
10
13
14
17
27
33
40
41
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
2
1
1
1
Sales/Revenue/Turnover
- -
670
- -
- -
-25,573.09
-3,814.86
-4,725.82
-1,050.54
-3,405.63
-2,356.54
-2,106.37
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
Depreciation Expense
- -
- -
-1
-2
-6
-11
-19
-22
-17
-18
-18
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
580
- -
- -
-25,586.15
-3,815.94
-4,725.82
-1,046.06
-3,366.6
-2,338.84
-2,091.19
Profit Margin (%)
- -
- -
- -
1
1
6
24
13
16
2
11
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
1
2
7
32
21
26
21
17
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
1,311.11
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
-240.5
-276.25
-92.65
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
40
40
48
Market Capitalization
118
111
116

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
10
6
13
Cash, Cash Equivalents & STI
8
4
12
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
4
2
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
130.01%
-18.59%
Free Cash Flow
- -
51.33%
37.94%
Net Income, GAAP
- -
32.84%
2.12%
Sales/Revenue/Turnover
- -
320.62%
46.99%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1
2025
- -
- -
- -
- -
1
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.17
-0.15
-0.11
-0.11
-0.52
2025
-0.1
-0.11
-0.11
-0.13
-0.45
2026
-0.09
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Bioextrax AB (publ) is a Swedish biotechnology company focused on developing and commercializing advanced bio-based extraction solutions. The firm's proprietary platform technology facilitates the sustainable conversion of organic waste and raw materials into various eco-friendly products. Using a completely chemical-free and bio-based method, it recovers bioplastics (PHA) granules from diverse carbon sources, alongside producing organic hydrolyzed protein, keratin microfibres, bio-oils, and amino acids from materials such as poultry feathers. Established in 2014 and headquartered in Lund, Sweden, the company operates on a licensing model, providing its patented process technologies and expertise to material producers aiming for more cost-effective and environmentally sound manufacturing. Bioextrax continues to expand its collaborations, as evidenced by recent extended partnerships with chemical companies, underscoring its commitment to advancing green solutions and fostering a circular economy.